 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Centers for Disease Control and Prevention</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Chorionic Villus Sampling Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) announces
the following meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Chorionic Villus Sampling (CVS) Meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 8:30 a.m.&hyph;5 p.m., Friday, March 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 CDC, Auditorium A, 1600 Clifton Road, NE., Atlanta, Georgia 30333.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Open to public for observation and comment, limited only by space available.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 CVS is an obstetrical diagnostic procedure done prenatally to detect genetic abnormalities. The safety of the procedure
has been questioned since infants have been reported with birth defects (limb deficiency) after their mothers had
undergone CVS. Studies have been published which both support and contradict the hypothesis that CVS has caused birth
defects. CDC has recently completed a multistate study investigating the association between limb deficiency and
CVS. CDC will convene this public meeting to discuss all recent studies of this issue and to receive advice from individual
participants on establishing public health recommendations for CVS utilization.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Matters to Be Discussed:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 An invited group of qualified individuals will be asked to provide comments on recent studies of limb deficiency after
CVS. The risk for these birth defects will be discussed in the context of other risks, benefits, and alternatives of
the procedure. A written commentary from CDC which provides recommendations for CVS utilization will also be discussed.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Contact Person for More Information:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 J. David Erickson, D.D.S., Ph.D., Chief, Birth Defects and Genetic Diseases Branch, Division of Birth Defects and
Developmental Disabilities, NCEH, CDC, Mailstop F&hyph;45, 4770 Buford Highway, NE, Atlanta, Georgia 30341&hyph;3724,
telephone 404/488&hyph;7160.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: February 17, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Elvin Hilyer,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;4124 Filed 2&hyph;23&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4163&hyph;18&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
